Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Singular Genomics Systems, Inc. (OMIC : NSDQ)

• Company Description    Singular Genomics Systems Inc. is a life science technology company. It focused on delivering genomic technologies for the advancement of science and medicine. Singular Genomics Systems Inc. is based in LA JOLLA, Calif. Number of Employees: 221

• Price / Volume Information    Yesterday's Closing Price: $2.99 Daily Weekly Monthly 20 Day Moving Average: 470,409 shares Shares Outstanding: 70.58 (millions) Market Capitalization: $211.05 (millions) Beta: 52 Week High: $33.37 52 Week Low: $2.87 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -33.85% -29.93% 12 Week -62.95% -59.52% Year To Date -74.14% -68.72%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3010 Science Park Road - SAN DIEGO,CA 92121 USA ph: 858-333-7830 fax: - None http://singulargenomics.com

• General Corporate Information    Officers Andrew Spaventa - Chief Executive Officer and Chair of the Board Dalen Meeter - Senior Vice President; Finance Michael Pellini - Lead Independent Director David Barker - Director Kim Kamdar - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 82933R100 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/02/22 Share - Related Items Shares Outstanding: 70.58 Most Recent Split Date: (:1) Beta: Market Capitalization: $211.05 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.34 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.37 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 18.52% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/02/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.68 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -14.81% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - -21.29 12/31/21 - -30.55 09/30/21 - -42.53 ROA 03/31/22 - -20.12 12/31/21 - -23.69 09/30/21 - -26.83 Current Ratio 03/31/22 - 35.87 12/31/21 - 51.57 09/30/21 - 60.80 Quick Ratio 03/31/22 - 35.18 12/31/21 - 51.57 09/30/21 - 60.80 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - 4.50 12/31/21 - 4.67 09/30/21 - 4.92 Inventory Turnover 03/31/22 - 0.00 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.03 12/31/21 - 0.03 09/30/21 - 0.03 Debt-to-Capital 03/31/22 - 3.04 12/31/21 - 2.86 09/30/21 - 2.73

Powered by Zacks Investment Research ©